R. Frampton

Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.

J. Eisman, R. J. Frampton, S. Omond, 1983, Cancer research.

Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats.

R. Larkins, H. Jonas, R. J. Frampton, 1990, Journal of developmental physiology.

Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells.

J. Eisman, E. Sher, R. J. Frampton, 1985, Endocrinology.

Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.

J. Eisman, T. Martin, D. Findlay, 1980, Cancer research.

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.

J. Eisman, L. Suva, T. Martin, 1982, Cancer research.

1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells).

J. Eisman, T. Martin, I. Macintyre, 1980, Biochemical and biophysical research communications.

Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells.

T. Martin, J. Grogan, H. Schneider, 1992, Endocrinology.